Literature DB >> 2458111

GABA/benzodiazepine receptor/chloride ionophore complex in brains of rat lines selectively bred for differences in ethanol-induced motor impairment.

O Malminen1, E R Korpi.   

Abstract

In vitro ligand binding studies were used to compare GABA/benzodiazepine receptor/chloride ionophore complexes in various brain regions of ethanol-sensitive ANT and ethanol-insensitive AT rats. In naive rats, there were several, but fairly small line differences in the binding parameters of [3H]muscimol and [3H]flunitrazepam to cerebral cortical, cerebellar or hippocampal membranes washed with or without a detergent. GABA-stimulation of flunitrazepam binding in the cerebral cortex membranes was slightly greater in the AT than ANT rats. In detergent solubilized receptors, the GABA-stimulation of flunitrazepam binding emerged only in the presence of ethanol in most AT samples, whereas the GABA-stimulation was always observed in ANT samples and ethanol had no further effect. Pharmacological characteristics of [3H]t-butylbicycloorthobenzoate binding displaceable by picrotoxin were similar in both lines. Chronic ethanol administration tended to increase the number of these binding sites in the cerebral cortex of AT rats and to decrease them in the ANT rats. Although many differences between the lines were observed, our results indicate that the ethanol-sensitivity difference between the AT and ANT rat lines cannot be explained by enhanced function of the GABA/benzodiazepine receptor/chloride ionophore complex as far as this is revealed by in vitro binding studies. It remains to be studied whether these lines differ in presynaptic GABAergic mechanisms or in the actual function of the postsynaptic chloride channels before the role of GABA can be more accurately assessed in this genetic model for ethanol-induced motor impairment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458111     DOI: 10.1016/0741-8329(88)90059-6

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  8 in total

1.  Cerebellar GABAA receptor binding and function in vitro in two rat lines developed for high and low alcohol sensitivity.

Authors:  M Uusi-Oukari; E R Korpi
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

2.  The cerebellar GABAAR α6-R100Q polymorphism alters ligand binding in outbred Sprague-Dawley rats in a similar manner as in selectively bred AT and ANT rats.

Authors:  Leena-Stiina Kontturi; Asko J Aalto; Martin Wallner; Mikko Uusi-Oukari
Journal:  Alcohol       Date:  2010-12-15       Impact factor: 2.405

3.  Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice.

Authors:  S S Oja; E R Korpi; P Saransaari
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

4.  Decreased levels of muscarinic receptors in bladders from the alcohol preferring rat line.

Authors:  R J Smyth; K Kiianmaa; M R Ruggieri
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

5.  A major QTL for acute ethanol sensitivity in the alcohol tolerant and non-tolerant selected rat lines.

Authors:  R A Radcliffe; V G Erwin; P Bludeau; X Deng; T Fay; K L Floyd; R A Deitrich
Journal:  Genes Brain Behav       Date:  2009-03-23       Impact factor: 3.449

Review 6.  The neurobiology of alcohol consumption and alcoholism: an integrative history.

Authors:  Boris Tabakoff; Paula L Hoffman
Journal:  Pharmacol Biochem Behav       Date:  2013-10-17       Impact factor: 3.533

7.  Neonatal administration of a GABA-T inhibitor alters central GABAA receptor mechanisms and alcohol drinking in adult rats.

Authors:  T Táira; T Porkka-Heiskanen; E R Korpi
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Evidence that genetic differences in habituation and GABAergic mechanisms may be related to sensitivity to ethanol and development of ethanol tolerance in mice.

Authors:  S Liljequist
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.